5Perz JB, Schonland SO, Hundemer M, et al. High-dose melphalan with autologous stem cell transplantation after VAD induction chemotherapy for treatment of amyloid light chain amyloidosis: a single centre prospective phase Ⅱ study [ J ]. Br J Haematol, 2004,127:543 -551.
二级参考文献6
1Rocken C, Sletten K. Amyloid in surgical pathology. Virchows Arch,2003, 443: 3-16.
2Black RM. Amyloidosis and light-chain deposition disease. In: Black RM,ed. Clinical problems in nephrology. Boston: Little, Brown,1996. 305-314.
3Park MA, Mueller PS, Kyle RA, et al. Primary (AL) hepatic amyloidosis: clinical features and natural history in 98 patients.Medicine, 2003, 82: 291-298.
4Goeminne A, Missault L, Bauwens F, et al. Clinical experience with cardiac amyloidosis. Acta Cardiol, 2003, 58: 143-147.
5Guy CD, Jones Ck. Abdominal fat pad aspiration biopsy for tissue confirmation of systemic amyloidosis: specificity, positive predictive value, and diagnostic pitfalls. Diagn Cytopathol, 2001,24:181-185.
5Bardwick P A,Zvaifler N J,Gill G N,et al.Plasma cell dyscra-sia with polyneuropathy,organomegaly,endocrinopathy,M protein and skin changes:the POEMS syndrome.Report on two cases and a review of the literature[J].Medicine(Baltimore),1980,59(4):311-22.
6Dispenzieri A.POEMS syndrome:2014 update on diagnosis,risk-stratification,and management[J].Am J Hematol,2014,89(2):214-23.
7Dispenzier A,Kyle R A,Lacy M Q,et al.POEMS syndrome:definitions and long-term outcome[J].Blood,2003,101(7):2496-506.
8Robillard N,Wuilleme S,Moreau P,Bene M C.Immunopheno-type of normal and myelomatous plasma-cell subsets[J].Front Immunol,2014,5:137.
9Kyle R A,Gentz M.Primary systemic amyloidosis:clincal and laboratory feathers in 474 cases[J].Semin Hematol,1995,32(1):45-59.
